Online Program

Promoting the consideration of equity in federal programs: An Implementation Strategy of the Federal Interagency Health Equity Team

Tuesday, November 3, 2015 : 10:50 a.m. - 11:10 a.m.

Onyemaechi Nweke, DrPH, MPH, Office of Minority Health/Office of the Secretary, Rockville, MD
From October 2014 through September 2015, the Federal Interagency Health Equity Team (FIHET) initiated a suite of activities to support peer programs, offices and agencies with integrating health equity considerations into their programs and policies.  The purpose of this presentation is to share this strategy, and discuss key activities implemented by the FIHET to support federal peer organizations with integrating health equity considerations into their policies and programs. The FIHET is a cross-sector, federal implementation body under the National Partnership for Action to End Health Disparities (NPA), with the mission to end health disparities by building capacity for equitable policies and programs, cultivating strategic partnerships, and sharing relevant models for action.

Learning Areas:

Public health or related public policy

Learning Objectives:
Describe the FIHET strategy for supporting federal programs to promote health equity through their programs. Explain at least 2-3 key activities that are helpful steps to enable an organization understand how its work relates to health equity.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the National Coordinator for the National Partnership for Acton to End Health Disparities, and Co-Chair for the Federal Interagency Health Equity Team. I am responsible for visioning for the NPA and FIHET, including the work presented. I also direct implementation of the activities related to implementing the NPA and mandate of the FIHET, including the activities discussed in this presentation.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.